Skip to content
Psychedelics Today cover art

All Episodes

Psychedelics Today — 779 episodes · page 4 of 8

#
Title
301

Psychedelics Weekly – Psilocybin-Assisted Psychotherapy for I.B.S., NY Aims to Legalize, and B.C.'s Decriminalization Experiment

302

PT380 – C.J. Spotswood, PMHNP-BC – Microdosing, Talking to Physicians About Psychedelics, and Nurses as the Scalability Solution

303

Psychedelics Weekly – Psilocybin and Stress Response, the Minnesota Medical Association Endorses Decriminalization, and Scott Wiener Introduces Senate Bill 58

304

PT379 – Sutton King, MPH – Intergenerational Trauma, Late-Stage Capitalism, and the Urban Indigenous Collective

305

Psychedelics Weekly – Prop 122 and Data Privacy, Ending the Crack/Cocaine Sentencing Disparity, and the High Cost of Psychedelic Therapy

306

PT378 – Zach Leary – Course Corrections, Preparation, and High-dose Experiences: "Who Are You Now?"

307

Psychedelics Weekly – Proposition 122 in Action, The Economics of Psychedelics, and Could States Legalize by 2037?

308

PT377 – Andrew Weil, M.D. – Integrative Medicine: Health, Wellness, and Psychedelics

309

Psychedelics Weekly – Genetic Memory, "The Psychedelic Renaissance," and Harm Reduction at Music Festivals

310

PT376 – Sherry Rais – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits

311

Psychedelics Weekly – Cannabis as an Adjunct Cancer Treatment & 5-MeO-DMT Reactivations

312

PT375 – James Fadiman, Ph.D., Adam Bramlage, & Conor Murray, Ph.D. – Microdosing & Citizen Science: Introducing the World's First Take-Home EEG Microdosing Study

313

Psychedelics Weekly – Bipartisan Political Movement & Psychedelics and Pain

314

PT374 – Marc Aixalà – Personalizing Psychedelic Integration

315

Psychedelics Weekly – Oregon Measure 109: Approaching the Proposed Final Rules

316

PT373 – Dr. Ben Medrano – Integrative Psychiatry & The Safety of At-Home Ketamine

317

Psychedelics Weekly – Wonderland Controversy and Colorado Proposition 122

318

PT372 – Jesse Gould & Zach Riggle – The Heroic Hearts Project: Veterans and The Impact of Storytelling

319

PT371 – Dennis Walker – The Trickster Archetype and the Need for Comic Relief

320

PT370 – Dana Larsen – Prohibition, Civil Disobedience, and The Coca Leaf Cafe

321

PT369 – Timothy Furnish, MD & Joel Castellanos, MD – Chronic Pain and Phantom Limb Pain: Could Psilocybin Be the Answer?

322

PT368 – Dr. Steven Radowitz – Ketamine, Group Work, and the Power of Just Being There

323

PT367 – David Bronner – Colorado Proposition 122 and the Decriminalization of Natural Medicines

324

PT366 – Drs. Rochelle & Dustin Hines – Neurotransmitter Systems and Novel Psychedelic Molecules

325

PT365 – Dr. Jennifer Montjoy – KAP: Self-Agency Through Intention, Titration, and Ceremony

326

PT364 – Jamie Wheal – Burning Man, Psychedelic Maturity, and Radical Hope

327

PT363 – Reggie Harris – Cannabis and Psilocybin: The Complications of Legality Inside an Endless Drug War

328

PT362 – Cory Firth – Psychedelic Storytelling: Transforming Out Loud

329

PT361 – Jason Slot, Ph.D. – Mycology and Evolutionary Genomics

330

PT360 – Stephanie Wang – Kanna: Love and Wholeness Through Nature's Alternative to MDMA

331

PT359 – Sawyer Hurwitz – Art, Philosophy, Sexuality, and "Psychedelics Tonight"

332

PT358 – Dr. Rick Barnett, Psy.D – Contexts of Use: Exploring the Various Paradigms of Psychedelics

333

PT357 – Dr. Hans Eriksson – Precision Psychiatry, Ketabon, and The Stress Response System

334

PT356 – Brom Rector – Investing in Psychedelics and The Rush to Improve on the Classics

335

PT355 – Ifetayo Harvey – The Drug War, Caregiving, and Blue Sky Thinking

336

PT354 – Laura Guzmán-Dávalos – Psilocybe, Microdosing, and Multigenerational Mycology

337

PT353 – Dr. James Fadiman, Dr. Sam Gandy, & Dr. David Luke – Psychedelics and Creativity

338

PT352 – Alex Enchin & Ian-Michael Hébert, MA – HOLOS: Returning to Wholeness Through Nature and Community

339

PT351 – Seth Rosenberg – The Trauma In Being Arrested and The Injustice of the Drug War

340

PT350 – Jim Gilligan – Psilocybin and Accessing the "Off" Switch For Nociplastic Pain

341

PT349 – Brenna Gebauer – Slowing Down, The Ethics of Touch, and The Value of Preparation

342

PT348 – Steve DeAngelo – Cannabis and Psychedelics: Industry, Consciousness, Justice, and Joy

343

PT347 – Christopher Koddermann – Rescheduling Psilocybin, Patents and IP, and The Entourage Effect

344

PT346 – Kevin Balktick – Horizons Northwest, The Psilocybin Services Act, and the Power of Gathering Together

345

PT345 – Steve Thayer, Ph.D. – Vital Psychedelic Conversations

346

PT344 – Susan Beaulieu – Epigenetics, Resilience, and Remembering

347

PT343 – Soren Shade – Kratom and Anti-Prohibition: Lessons Learned and Applied

348

PT342 – Spencer Hawkswell – The Right to Psilocybin in Canada: TheraPsil's Charter Challenge

349

PT341 – Monnica Williams, Ph.D. – Racism, Trauma, Research, and Psychedelics

350

PT340 – Joost Breeksema – The Interdisciplinary Conference on Psychedelic Research (ICPR) & The Patient Perspective

351

PT339 – Kim Dudine – Cannabis: The Gateway Drug to Unity Consciousness

352

PT338 – Melissa Lavasani – The Power of Storytelling, The Preservation of Peyote, and "How to Change Your Mind"

353

PT337 – Lauren Katalinich & Anya Oleksiuk – The Psychedelic Society: The Power of Community and The Color of Teal

354

PT336 – Sisi Li, Ph.D. – Porta Sophia: Psychedelic Prior Art

355

PT335 – Christopher Dawson & Andrew Galloway – Modernizing Traditional Plant Medicine With Neuroscience and Luxury

356

PT334 – Prof. David Nutt – The Human Brain, Addiction, and Telling the Truth About Drugs

357

PT333 – Miriam Volat, MS & T. Cody Swift, MFA – Conservation, Peyote, and Indigenous Biocultural Survival

358

PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

359

PT331 – Julie Zukof & Dr. Michelle Weiner – Psychedelic Women, Coaching, and Ketamine For Fibromyalgia

360

PT330 – Dick Simon – Researching Ethnobotanical Efficacy and the Search For New Therapeutic Molecules

361

PT329 – Dr. Scott Shannon – The Board of Psychedelic Medicine and Therapies

362

PT328 – Courtney Watson, LMFT – Ancestral Veneration and Psychedelic-Assisted Therapy For (and By) QTBIPOC

363

PT327 – Rick Doblin, Ph.D. – Confronting Abuse in Clinical Trials and the Future of Psychedelic Medicine

364

PT326 – Dr. Rick Barnett, Psy.D – Addiction, Recovery, and Competency in Psychedelic Therapy

365

PT325 – Philip Wolf – Cannabis: The Early Days of Legality, Elevated Dining, and the Need for Education

366

PT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and A Deeper Relationship With Plants

367

PT323 – Dr. Reid Robison & Steve Thayer, Ph.D. – Ketamine-Assisted Psychotherapy, Therapist Burnout, and LSD for Anxiety

368

PT322 – Kimberly Juroviesky, Capt, USAF, Retired – Ketamine and Complex Regional Pain Syndrome

369

PT321 – Lyle Maxson – Virtual Reality, Biofeedback, and Digital Therapeutics: The Future of Mental Health

370

PT320 – Anne Philippi – The New Health Club, Intergenerational Trauma, and Psychedelics in the Workplace

371

PT319 – Kole – Activism and Trust: A Cautionary Tale From Someone Who Got Caught

372

PT318 – Del Jolly, Rashad Evans, and Jake Plummer – Functional Mushrooms, Brain Injuries, and the Importance of Slowing Down

373

PT317 – Jason Grechanik – Ancient Wisdom, Plant Dietas, and The Universe Within

374

PT316 – Lenny Gibson, Ph.D. – Vital Psychedelic Conversations

375

PT315 – Dr. Dominique Morisano – From Research to Reality: Planning a Global Psychedelic Summit

376

PT314 – Daniel McQueen, MA – Vital Psychedelic Conversations

377

PT313 – Christine Calvert, LCDC – Holotropic Breathwork, Ethics, and Dying To Ourselves

378

PT312 – Deborah Snyder – Ecology, Synergy, and the Biosphere

379

PT311 – William Leonard Pickard – LSD, Fentanyl, Prison, and the Greatest Gift of All: The Natural Mind

380

PT310 – Omar Thomas – Vital Psychedelic Conversations

381

PT309 – Jon Dennis, Esq. – Oregon's Measure 109 and the Fight For Religious Liberty

382

PT308 – Dr. Ido Cohen, PsyD – Vital Psychedelic Conversations

383

PT307 – Kathryn L. Tucker, JD – The Right to Try Act and the Battle for Psilocybin Access

384

PT306 – Dr. Devon Christie – Vital Psychedelic Conversations

385

PT305 – Emma Farrell – Plant Spirits, Entities, and Remembering Lost Traditions

386

PT304 – Jerry B. Brown, Ph.D. – Vital Psychedelic Conversations

387

PT303 – Adam Bramlage – Cannabis, Microdosing, and Our Evolutionary Connection to Psychedelics

388

PT302 – Dr. Adele Lafrance – Vital Psychedelic Conversations

389

PT301 – Kabir Ali – Addiction, Ketamine, and the Overlooked Gift of Self-Love

390

PT300 – Dr. Richard C. Schwartz – Vital Psychedelic Conversations

391

PT299 – Ed Prideaux – HPPD (Hallucinogen Persisting Perception Disorder): A Synopsis

392

PT298 – Michael Sapiro, PsyD – Vital Psychedelic Conversations

393

PT297 – Laura Mae Northrup, LMFT – Radical Healership in a Profit-Driven World

394

PT296 – Dr. David Luke – Vital Psychedelic Conversations

395

PT295 – Sidarta Ribeiro – Dreams, LSD, and Biopiracy

396

PT294 – Andrew Tatarsky, Ph.D. & Juliana Mulligan – Vital Psychedelic Conversations

397

PT293 – Stanislav & Brigitte Grof – The Evolution of Breathwork and The Psychology of the Future

398

PT292 – Sam Gandy – Vital Psychedelic Conversations

399

PT291 – Rick Tarnas & Sean Kelly, Ph.D. – The Impact of Stanislav Grof, Ego Death, and the Psyche Unbound

400

PT290 – Kylea Taylor, M.S., LMFT – Vital Psychedelic Conversations